CVET

Covetrus, Inc. [CVET] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CVET Stock Summary

In the News

09:51 29 Sep 2023 CVET

CD&R, TPG Take Covetrus Private In $4B Deal

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates.

08:49 29 Sep 2023 CVET

Covetrus going private in $4 billion deal

Animal health company Covetrus Inc. CVET, -0.20% said Wednesday it agreed to be taken private by Clayton, Dubilier & Rice (CD&R) and TPG Capital TPG, -0.90% in a deal valued at $4 billion. The two private equity firms agreed to pay $21 a share, which is $1.34 or 6.8% over its closing price of $19.66 a share on Tuesday and a 39% premium over its 30-day volume weighted average price per share as of the unaffected stock price as of May 13.

08:44 29 Sep 2023 CVET

Covetrus to Be Taken Private for $4 Billion

Private-equity firms CD&R and TPG Capital will pay $21 a share to acquire the veterinary services company.

08:29 29 Sep 2023 CVET

Covetrus Gets Private-Equity Buyout Offer at $21 a Share

CD&R and TPG offer to pay $21 a share in cash for Covetrus, which develops technologies and services for the animal health industry.

08:19 29 Sep 2023 CVET

Covetrus (CVET) Q1 Earnings Surpass Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 8.70% and 0.32%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

11:22 29 Sep 2023 CVET

Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript

Covetrus, Inc. (CVET) CEO Ben Wolin on Q4 2021 Results - Earnings Call Transcript

08:00 29 Sep 2023 CVET

Covetrus (CVET) Q4 Earnings Surpass Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 4% and 1.40%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

07:04 29 Sep 2023 CVET

Covetrus (CVET) Matches Q3 Earnings Estimates

Covetrus (CVET) delivered earnings and revenue surprises of 0.00% and -0.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

04:31 29 Sep 2023 CVET

Covetrus: Q3 Earnings Insights

Covetrus (NASDAQ:CVET) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

08:30 29 Sep 2023 CVET

Covetrus Announces Third Quarter 2021 Earnings Release Date and Conference Call Information

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus will release Q3 2021 results after the market close on Thursday, November 4, 2021 and the company will hold a conference call at 4:30 PM ET.

CVET Financial details

Company Rating
Buy
Market Cap
0
Income
-13M
Revenue
4.65B
Book val./share
10.75
Cash/share
0.62
Dividend
-
Dividend %
-
Employees
4.04K
Optionable
No
Shortable
Yes
Earnings
02 Nov 2022
P/E
-489.77
Forward P/E
-
PEG
118.73
P/S
-
P/B
1.95
P/C
-
P/FCF
-
Quick Ratio
1.01
Current Ratio
1.88
Debt / Equity
1.24
LT Debt / Equity
0.65
-
-
EPS (TTM)
-0.09
EPS next Y
-
EPS next Q
0.24
EPS this Y
293.75%
EPS next Y
-
EPS next 5Y
-1115.96%
EPS last 5Y
NAN%
Revenue last 5Y
5.03%
Revenue Q/Q
6.01%
EPS Q/Q
97.24%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
19%
Oper. Margin
1%
Profit Margin
-
Payout
-
Shs Outstand
140.12M
Shs Float
105.28M
-
-
-
-
Target Price
-
52W Range
13.39-21.2
52W High
-
52W Low
-
RSI
-
Rel Volume
4.36
Avg Volume
1.22M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.50574
-
-
Volatility
9.89%, 9.89%
Prev Close
-
Price
-
Change
-

CVET Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
32.1933.9837.1636.7733.39
Net income per share
0.580.91-9.52-0.16-0.39
Operating cash flow per share
0.971.420.960.450.74
Free cash flow per share
0.791.220.6-0.040.31
Cash per share
0.150.211.212.461.34
Book value per share
10.9113.4311.7413.0311.03
Tangible book value per share
2.244.82-5.06-1.74-1.28
Share holders equity per share
10.9113.4311.7413.0311.03
Interest debt per share
0.240.2211.629.467.87
Market cap
4.67B4.67B1.41B3.39B2.74B
Enterprise value
4.68B4.67B2.47B4.17B3.6B
P/E ratio
72.5746.3-1.39-178.49-50.66
Price to sales ratio
1.31.240.360.780.6
POCF ratio
43.1729.5813.7163.9926.82
PFCF ratio
53.3634.3722.07-678.2665.14
P/B Ratio
3.853.131.122.211.81
PTB ratio
3.853.131.122.211.81
EV to sales
1.311.240.620.960.79
Enterprise value over EBITDA
27.323.12-3.1119.7620.22
EV to operating cash flow
43.2629.5823.9778.6935.28
EV to free cash flow
53.4734.3838.58-834.0685.69
Earnings yield
0.010.02-0.72-0.01-0.02
Free cash flow yield
0.020.030.0500.02
Debt to equity
0.790.51.681.271.26
Debt to assets
0.440.330.630.560.56
Net debt to EBITDA
0.060-1.333.694.85
Current ratio
2.111.91.622.071.94
Interest coverage
00-17.8-1.47-0.72
Income quality
1.681.57-0.1-2.79-1.89
Dividend Yield
000.8300
Payout ratio
00-1.15-0.320
Sales general and administrative to revenue
0.140.140.20.20
Research and developement to revenue
00000
Intangibles to total assets
0.440.430.530.50.49
Capex to operating cash flow
-0.19-0.14-0.38-1.09-0.59
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.35-0.34-0.22-0.31-0.3
Stock based compensation to revenue
000.010.010.01
Graham number
11.9216.5650.156.879.89
ROIC
0.050.06-0.38-0.02-0.01
Return on tangible assets
0.050.08-0.65-0.01-0.03
Graham Net
-2.64-0.67-12.03-8.25-7.36
Working capital
565.34M514.04M511M740M653M
Tangible asset value
249.3M535.64M-541M-205M-175M
Net current asset value
121.9M347.14M-765M-528M-548M
Invested capital
0.020.020.950.70.69
Average receivables
463.6M491.76M486.5M533.5M564.5M
Average payables
358.48M408.62M480.73M462.5M423.5M
Average inventory
504.16M549.41M600.08M583M556.5M
Days sales outstanding
51.3446.3745.2648.2944.28
Days payables outstanding
46.8552.0858.8241.7543.4
Days of inventory on hand
66.6666.5671.9454.6357.25
Receivables turnover
7.117.878.067.568.24
Payables turnover
7.797.016.218.748.41
Inventory turnover
5.485.485.076.686.38
ROE
0.050.07-0.81-0.01-0.04
Capex per share
-0.19-0.2-0.36-0.49-0.44

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
8.688.488.138.328.69
Net income per share
-0.23-0.03-0.02-0.01-0.03
Operating cash flow per share
0.420.430.32-0.24-0.04
Free cash flow per share
0.340.330.16-0.32-0.15
Cash per share
1.681.361.330.850.62
Book value per share
10.9610.9610.9511.0710.75
Tangible book value per share
-1.23-1.64-1.27-0.95-0.86
Share holders equity per share
10.9610.9610.9511.0710.75
Interest debt per share
7.887.897.627.647.54
Market cap
3.7B2.49B2.76B2.32B2.91B
Enterprise value
4.54B3.37B3.62B3.25B3.87B
P/E ratio
-29.83-155.32-229.66-289.63-181.56
Price to sales ratio
3.112.142.462.022.39
POCF ratio
63.7842.1262.63-70.21-484.17
PFCF ratio
78.755.23125.27-52.66-138.33
P/B Ratio
2.461.651.821.521.93
PTB ratio
2.461.651.821.521.93
EV to sales
3.822.93.232.833.18
Enterprise value over EBITDA
100.8978.47757.9874.37
EV to operating cash flow
78.2857.1482.25-98.39-644.5
EV to free cash flow
96.674.92164.49-73.8-184.14
Earnings yield
-0.010000
Free cash flow yield
0.010.020.01-0.02-0.01
Debt to equity
1.271.281.261.261.24
Debt to assets
0.560.560.560.550.55
Net debt to EBITDA
18.6920.618.3616.6118.5
Current ratio
21.891.941.861.88
Interest coverage
-1-0.5-1.170.860.57
Income quality
-1.87-14.75-14.6716.51.5
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.490.50.490.480.48
Capex to operating cash flow
-0.19-0.24-0.50.332.5
Capex to revenue
-0.01-0.01-0.02-0.01-0.01
Capex to depreciation
-0.2-0.29-0.43-0.23-0.31
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
7.472.682.311.92.63
ROIC
-0.010000
Return on tangible assets
-0.020000
Graham Net
-6.98-7.51-7.31-7.38-7.13
Working capital
710M637M653M655M645M
Tangible asset value
-169M-224M-175M-131M-121M
Net current asset value
-493M-567M-548M-503M-493M
Invested capital
0.710.710.690.690.7
Average receivables
600.5M582M561.5M591M641.5M
Average payables
421.5M427.5M435M474.5M476.5M
Average inventory
556M554.5M567.5M606.5M608.5M
Days sales outstanding
45.1143.9944.5249.1648.51
Days payables outstanding
39.6640.7243.7149.4440.63
Days of inventory on hand
51.7352.5257.6661.4353.47
Receivables turnover
1.992.052.021.831.86
Payables turnover
2.272.212.061.822.22
Inventory turnover
1.741.711.561.471.68
ROE
-0.020000
Capex per share
-0.08-0.1-0.16-0.08-0.11

CVET Frequently Asked Questions

What is Covetrus, Inc. stock symbol ?

Covetrus, Inc. is a US stock , located in Portland of Maine and trading under the symbol CVET

What is Covetrus, Inc. stock quote today ?

Covetrus, Inc. stock price is $- today.

Is Covetrus, Inc. stock public?

Yes, Covetrus, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector